You are here

JFDA approves emergency use of Johnson & Johnson’s COVID vaccine

By JT - Mar 01,2021 - Last updated at Mar 01,2021

AMMAN — The Jordan Food and Drug Administration (JFDA) said on Monday that the administration approved the emergency use of the Johnson & Johnson’s COVID-19 vaccine, JFDA Director General Nizar Muhaidat said in a statement carried by the Jordan News Agency, Petra. 

Johnson & Johnson’s vaccine is the fourth to be approved by the JFDA, after Pfizer, Sinopharm and AstraZeneca.

 

 

 

 

 

up
7 users have voted.


Newsletter

Get top stories and blog posts emailed to you each day.

PDF